Warning: The NCBI web site requires JavaScript to function. more...
Development of bisphosphonates.
Fleisch H.
Breast Cancer Res. 2002;4(1):30-4. Epub 2001 Nov 30. Review.
Related citations
Bisphosphonates: from the laboratory to the clinic and back again.
Russell RG, Rogers MJ.
Bone. 1999 Jul;25(1):97-106. Review.
Bisphosphonates: the first 40 years.
Russell RG.
Bone. 2011 Jul;49(1):2-19. Epub 2011 May 1. Review.
Mechanisms of action of the bisphosphonates.
Medicina (B Aires). 1997;57 Suppl 1:65-75.
Bisphosphonates: preclinical aspects and use in osteoporosis.
Fleisch HA.
Ann Med. 1997 Feb;29(1):55-62. Review.
[Introduction to bisphosphonates. History and functional mechanisms].
Orthopade. 2007 Feb;36(2):103-4, 106-9. Review. German.
Experimental basis for the use of bisphosphonates in Paget's disease of bone.
Clin Orthop Relat Res. 1987 Apr;(217):72-8. Review.
Bisphosphonates: from bench to bedside.
Ann N Y Acad Sci. 2006 Apr;1068:367-401. Review.
Bisphosphonates in the treatment of malignant bone disease.
Berenson JR, Lipton A.
Annu Rev Med. 1999;50:237-48. Review.
Bisphosphonates: mode of action and pharmacology.
Pediatrics. 2007 Mar;119 Suppl 2:S150-62. Review.
Bisphosphonates in osteoporosis: an introduction.
Osteoporos Int. 1993;3 Suppl 3:S3-5.
The relationship between the chemistry and biological activity of the bisphosphonates.
Ebetino FH, Hogan AM, Sun S, Tsoumpra MK, Duan X, Triffitt JT, Kwaasi AA, Dunford JE, Barnett BL, Oppermann U, Lundy MW, Boyde A, Kashemirov BA, McKenna CE, Russell RG.
Bone. 2011 Jul;49(1):20-33. Epub 2011 Apr 9. Review.
Bisphosphonates: a new class of drugs in diseases of bone and calcium metabolism.
Recent Results Cancer Res. 1989;116:1-28. Review.
New bisphosphonates in osteoporosis.
Osteoporos Int. 1993;3 Suppl 2:S15-22. Review.
Bisphosphonates in the treatment of metabolic bone diseases.
Rodan GA, Balena R.
Ann Med. 1993 Aug;25(4):373-8. Review.
Cellular and molecular mechanisms of action of bisphosphonates.
Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, Frith JC.
Cancer. 2000 Jun 15;88(12 Suppl):2961-78. Review.
Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
Russell RG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, Kavanagh KL, Triffitt JT, Lundy MW, Phipps RJ, Barnett BL, Coxon FP, Rogers MJ, Watts NB, Ebetino FH.
Ann N Y Acad Sci. 2007 Nov;1117:209-57. Review.
[Inhibitory effects of bisphosphonates on bone resorption].
Shinoda H.
Nihon Yakurigaku Zasshi. 1995 May;105(5):285-94. Review. Japanese.
Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.
Dunford JE, Thompson K, Coxon FP, Luckman SP, Hahn FM, Poulter CD, Ebetino FH, Rogers MJ.
J Pharmacol Exp Ther. 2001 Feb;296(2):235-42.
Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates.
van Beek ER, Cohen LH, Leroy IM, Ebetino FH, Löwik CW, Papapoulos SE.
Bone. 2003 Nov;33(5):805-11.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on